Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FUTIBATINIB vs GADODIAMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FUTIBATINIB vs GADODIAMIDE: Safety Overview

Metric FUTIBATINIB GADODIAMIDE
Total FAERS Reports 161 777
Deaths Reported 38 37
Death Rate 23.6% 4.8%
Hospitalizations 60 67
Average Patient Age 61.8 yrs 49.7 yrs
% Female Patients 51.3% 64.6%
FDA Approval Date Jul 28, 2025 Jan 8, 1993
Manufacturer TAIHO PHARMACEUTICAL CO., LTD. GE Healthcare Inc.
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription